CYP2E1 and Alzheimer disease: Similarly, transplantation of human AD-MSCs effectively reduced CYP2E1 expression, increased the activity of the acetaldehyde-metabolizing enzyme ALDH2, and mitigated alcohol-induced damage, such as lipid accumulation and fibrosis [142].